Lv3
234 积分 2024-03-14 加入
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study
1个月前
已完结
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
1个月前
已完结
Rapidly Enlarging “Bruise” on the Back of an Infant
2个月前
已完结
Cutaneous angiosarcoma
2个月前
已关闭
Cutaneous Angiosarcoma
2个月前
已完结
Cutaneous Malignant Vascular Neoplasms
2个月前
已完结
Histiocytic Sarcoma and Hemangiosarcoma Update
2个月前
已完结
Radiation-induced Angiosarcoma as a Cause of Pleural Effusion
2个月前
已完结
Incidence and Presenting Characteristics of Angiosarcoma in the US, 2001-2020
2个月前
已完结
Biologically explicable multimodal model predicting local tumor progression and tumor invasiveness of hepatocellular carcinoma
2个月前
已完结
皖公网安备34019202002308
